Humana Inc. (NYSE:HUM) Stock Holdings Boosted by Swedbank AB

Swedbank AB boosted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 3.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,976 shares of the insurance provider's stock after acquiring an additional 3,085 shares during the period. Swedbank AB owned about 0.09% of Humana worth $33,567,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Pzena Investment Management LLC grew its holdings in shares of Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider's stock worth $866,250,000 after buying an additional 1,955,375 shares in the last quarter. Ontario Teachers Pension Plan Board grew its holdings in shares of Humana by 11,647.2% during the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider's stock worth $367,342,000 after buying an additional 1,050,459 shares in the last quarter. Marshall Wace LLP grew its holdings in Humana by 118.9% in the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider's stock valued at $532,564,000 after purchasing an additional 774,085 shares during the period. Steadfast Capital Management LP purchased a new stake in Humana in the first quarter valued at approximately $158,813,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in Humana by 255.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider's stock valued at $215,241,000 after purchasing an additional 446,124 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on HUM shares. Truist Financial lowered their target price on shares of Humana from $400.00 to $260.00 and set a "hold" rating for the company in a report on Friday, October 11th. Stephens reiterated an "equal weight" rating and set a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Royal Bank of Canada decreased their price objective on shares of Humana from $400.00 to $265.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. JPMorgan Chase & Co. boosted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 21st. Finally, Jefferies Financial Group cut shares of Humana from a "buy" rating to a "hold" rating and reduced their target price for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. One analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $315.33.

Humana Stock Performance

HUM stock traded up $10.94 during trading on Thursday, hitting $266.51. 3,693,526 shares of the company's stock traded hands, compared to its average volume of 1,832,702. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $529.86. The stock has a fifty day moving average price of $319.24 and a two-hundred day moving average price of $339.00. The stock has a market capitalization of $32.11 billion, a price-to-earnings ratio of 16.59, a price-to-earnings-growth ratio of 1.91 and a beta of 0.50.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm had revenue of $29.54 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the previous year, the firm earned $8.94 earnings per share. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts anticipate that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. Humana's dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.